The Smallest Artificial Pancreas System Receives FDA Clearance
Tandem Mobi—a miniature-sized insulin pump, for use with Tandem’s Control-IQ™ technology and a compatible CGM—received FDA clearance.
Breakthrough T1D 2023 Children’s Congress Makes Waves in Washington
Delegates with type 1 diabetes at Breakthrough T1D 2023 Children's Congress fought for the special diabetes program and insulin affordability.
At ADA 2023, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
Breakthrough T1D joined thousands at the ADA's Scientific Sessions, where experts presented significant advancements in diabetes research and clinical trials.
ADA’s Scientific Sessions: Takeaways Day 3
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for…
ADA’s Scientific Sessions: Takeaways Day 2
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for…
ADA’s Scientific Sessions: Takeaways Day 1
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for…
Still Riding After All These Years
Dick and Julie Roettker have been Breakthrough T1D Ride participants since the beginning. Read their incredible story and learn more…
Breakthrough T1D Heads to ADA’s 83rd Scientific Sessions Diabetes Conference
From June 23-26, Breakthrough T1D researchers will present new study results at the American Diabetes Association's 83rd Scientific Sessions.
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
Common (and less common) symptoms of type 1 diabetes
Learn about the common and less common symptoms of type 1 diabetes (T1D), including frequent urination, weight loss, and vision…
